S

SEC Clinical Research | Dothan, AL

Research site
(Unclaimed)
Location
3138 Ross Clark Circle, Dothan, Alabama, United States of America
Site insights

Top conditions

Atrial Fibrillation (2 trials)

Hypercholesterolemia (1 trial)

Atherosclerosis (1 trial)

Human Influenza (1 trial)

Cardiovascular Diseases (1 trial)

Top treatments

Apixaban
Ezetimibe

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 6
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Enrolling
Atrial Fibrillation
Drug: Placebo
Drug: Apixaban Placebo
Locations recently updated

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who hav...

Enrolling
Atherosclerotic Cardiovascular Disease (ASCVD)
Elevated Lp(a)
Drug: Lepodisiran Sodium
Drug: Placebo

CKJX839D12304 is a research study to determine if the study treatment, called inclisiran, in comparison to placebo or ezetimibe can effectively reduc...

Enrolling
Hypercholesterolemia
Drug: Ezetimibe
Drug: Inclisiran

Trial sponsors

Bayer logo

Bayer (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems